PROBELPHARMA
ActiveFinancials · financial year 2025, micro format
Annual accounts 2025 filed on 26-06-2026 at the NBB all 26 filings
2021 to 2025, 5 financial years 2018 to 2025, 8 financial years
The operating result for 2025 is a loss of €3,881, larger than the loss of €3,265 in 2024.
Turnover is what the company sold, the result is what was left of it. A loss stands below the zero line.
Assets, equity and debt per financial year.
Above zero, the company can pay its short-term debts with what it holds in the short term.
Use the arrow keys on the chart for the figures per year.
Investments
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Financial fixed assets | - | - | €1,487 | - | - |
Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Other operating charges640/8 | - | - | - | - | €150 | €6,309 | €0 | - | - |
| Gross operating margin9900 | -€2,816 | -€3,570 | -€3,749 | -€2,816 | -€9,420 | -€3,483 | -€3,265 | -€3,881 | ▼ 18.9% |
| Operating profit (loss)9901 | -€2,816 | -€22,410 | -€8,261 | -€2,816 | -€9,570 | -€9,792 | -€3,265 | -€3,881 | ▼ 18.9% |
| Financial income75/76B | - | - | - | €466 | €0 | €2,112 | €1,005 | €1,504 | ▲ 49.7% |
| Recurring financial income75 | €8 | €731 | €708 | €466 | €0 | €2,112 | €1,005 | €1,504 | ▲ 49.7% |
| Financial charges65/66B | - | - | - | €1,423 | €1,268 | €1,223 | €1,124 | €1,179 | ▲ 4.9% |
| Recurring financial charges65 | €1,200 | €1,261 | €1,286 | €1,423 | €1,268 | €1,223 | €1,124 | €1,179 | ▲ 4.9% |
| Profit (loss) for the period before taxes9903 | -€12,171 | -€22,940 | -€8,839 | -€3,774 | -€10,837 | -€8,904 | -€3,384 | -€3,556 | ▼ 5.1% |
| Profit (loss) for the period9904 | -€12,171 | -€22,940 | -€8,839 | -€3,774 | -€10,837 | -€8,904 | -€3,384 | -€3,556 | ▼ 5.1% |
| Profit (loss) for the period to be appropriated9905 | -€12,171 | -€22,940 | -€8,839 | -€3,774 | -€10,837 | -€8,904 | -€3,384 | -€3,556 | ▼ 5.1% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total assets20/58 | €355,332 | €331,883 | €322,563 | €319,329 | €308,347 | €306,780 | €296,278 | €293,072 | ▼ 1.1% |
| Fixed assets21/28 | €278,136 | €284,086 | €285,573 | €285,573 | €285,573 | €287,060 | €287,060 | €287,060 | = |
| Financial fixed assets28 | €278,136 | €284,086 | €285,573 | €285,573 | €285,573 | €287,060 | €287,060 | €287,060 | = |
| Current assets29/58 | €77,196 | €47,797 | €36,989 | €33,755 | €22,774 | €19,719 | €9,217 | €6,012 | ▼ 34.8% |
| Amounts receivable within one year40/41 | €191 | €498 | €498 | €498 | €498 | €498 | €498 | €498 | = |
| Other amounts receivable41 | - | - | - | €498 | €498 | €498 | €498 | €498 | = |
| Cash at bank and in hand54/58 | €77,005 | €47,299 | €36,492 | €33,258 | €22,276 | €19,222 | €8,719 | €5,514 | ▼ 36.8% |
| Equity and liabilities | |||||||||
| Total equity and liabilities10/49 | €355,332 | €331,883 | €322,563 | €319,329 | €308,347 | €306,780 | €296,278 | €293,072 | ▼ 1.1% |
| Equity10/15 | €183,583 | €159,652 | €150,813 | €147,039 | €136,202 | €127,298 | €123,914 | €120,358 | ▼ 2.9% |
| Contributions10/11 | €17,473 | €16,481 | - | €16,481 | €16,481 | €16,481 | €16,481 | €16,481 | = |
| Reserves13 | €3,992 | €3,992 | €3,992 | €3,992 | €3,992 | €3,992 | €3,992 | €3,992 | = |
| Non-distributable reserves130/1 | - | - | - | €0 | - | - | - | - | - |
| Reserves not available under the articles1311 | - | - | - | €0 | - | - | - | - | - |
| Distributable reserves133 | - | - | - | €3,992 | €3,992 | €3,992 | €3,992 | €3,992 | = |
| Profit (loss) carried forward14 | €162,118 | €139,178 | €130,340 | €126,566 | €115,728 | €106,825 | €103,440 | €99,884 | ▼ 3.4% |
| Amounts payable17/49 | €171,749 | €172,231 | €171,749 | €172,289 | €172,145 | €179,482 | €172,364 | €172,714 | ▲ 0.2% |
| Amounts payable within one year42/48 | €171,749 | €172,231 | €171,749 | €172,289 | €172,097 | €179,434 | €172,364 | €172,714 | ▲ 0.2% |
| Trade debts44 | - | €482 | - | €540 | €348 | €1,014 | €390 | €740 | ▲ 89.9% |
| Suppliers440/4 | - | - | - | €540 | €348 | €1,014 | €390 | €740 | ▲ 89.9% |
| Other amounts payable47/48 | - | - | - | €171,749 | €171,749 | €178,419 | €171,974 | €171,974 | = |
| Accrued charges and deferred income492/3 | - | - | - | - | €48 | €48 | €0 | - | - |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€12,171 | -€22,940 | -€8,839 | -€3,774 | -€10,837 | -€8,904 | -€3,384 | -€3,556 | ▼ 5.1% |
| Operating cash flow (approximation) | -€12,171 | -€22,940 | -€8,839 | -€3,774 | -€10,837 | -€8,904 | -€3,384 | -€3,556 | ▼ 5.1% |
| Investment in fixed assets (approximation) | - | -€5,949 | -€1,487 | €0 | €0 | -€1,487 | €0 | €0 | - |
| Change in cash | - | -€29,706 | -€10,808 | -€3,234 | -€10,982 | -€3,054 | -€10,502 | -€3,206 | ▲ 69.5% |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Latest 10 of 26 filings with the National Bank
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | micro format | 26-06-2026 | 2026-00235043 | NBB |
| 31-12-2024 | micro format | 30-09-2025 | 2025-00521636 | |
| 31-12-2023 | micro format | 24-06-2024 | 2024-00171775 | |
| 31-12-2022 | micro format | 05-07-2023 | 2023-00219378 | |
| 31-12-2021 | micro format | 24-06-2022 | 2022-20097627 | |
| 31-12-2020 | full format | 02-07-2021 | 2021-29800440 | |
| 31-12-2019 | full format | 04-09-2020 | 2020-51000062 | |
| 31-12-2018 | full format | 07-06-2019 | 2019-16700305 | |
| 31-12-2017 | full format | 13-06-2018 | 2018-18000092 | |
| 31-12-2016 | full format | 10-06-2017 | 2017-16500348 |